Literature DB >> 2017152

Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction.

W Gross1, M J Lohse.   

Abstract

Existing models describing the kinetics of receptor-effector interaction were found to be insufficient to account for the experimental findings on adenylate cyclase activation by A2 adenosine receptors described in the preceding manuscript [Mol. Pharmacol. 39: 517-523 (1991)]. We have, therefore, chosen another approach and have developed discrete computer simulations of receptor-effector interactions taking place on a spherical membrane. These simulations were based on the following principles: (a) receptors activate effectors in a catalytic manner, and (b) diffusion of receptors and effectors is slow, so that receptors will only activate effectors that are in their vicinity at the time of agonist occupation. Using several experimentally determined parameters, these simulations could reproduce the experimental findings on adenylate cyclase activation by A2 adenosine receptors described in the preceding manuscript. In addition, by appropriate choice of the simulation parameters, they are shown to accommodate the behavior of several other models of receptor-effector interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017152

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Dynamics of receptor/G protein coupling in living cells.

Authors:  Peter Hein; Monika Frank; Carsten Hoffmann; Martin J Lohse; Moritz Bünemann
Journal:  EMBO J       Date:  2005-11-17       Impact factor: 11.598

Review 2.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

3.  Allosteric equilibrium model explains steady-state coupling of beta-adrenergic receptors to adenylate cyclase in turkey erythrocyte membranes.

Authors:  O Ugur; H O Onaran
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 4.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 5.  Complex information processing by the transmembrane signaling system involving G proteins.

Authors:  S Offermanns; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

Review 6.  The GPCR heterotetramer: challenging classical pharmacology.

Authors:  Sergi Ferré
Journal:  Trends Pharmacol Sci       Date:  2015-02-18       Impact factor: 14.819

7.  Adenosine A2A receptor signaling and golf assembly show a specific requirement for the gamma7 subtype in the striatum.

Authors:  William F Schwindinger; Lauren J Murphree Mihalcik; Kathryn E Giger; Kelly S Betz; Anna Maria Stauffer; Joel Linden; Denis Herve; Janet D Robishaw
Journal:  J Biol Chem       Date:  2010-07-16       Impact factor: 5.157

8.  125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

Authors:  T M Palmer; S M Poucher; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

9.  Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.

Authors:  A Varrault; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

10.  Rapid-mix flow cytometry measurements of subsecond regulation of G protein-coupled receptor ternary complex dynamics by guanine nucleotides.

Authors:  Yang Wu; Tione Buranda; Peter C Simons; Gabriel P Lopez; William E McIntire; James C Garrison; Eric R Prossnitz; Larry A Sklar
Journal:  Anal Biochem       Date:  2007-08-14       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.